HES1 and colorectal adenocarcinoma: Additionally, a previous study noted that loss of nuclear expression of HES1 in colorectal adenocarcinoma was markedly associated with female sex, right-sided location, BRAFV600E mutation, microsatellite instability, larger tumor size, and worse survival [24].